If I made (a poor technical) reference to biphenotypic acute leukaemia t-cell with no inversions or over-expressions I suspect you are one of but a few who would understand my interest in CYP amongst one or two other bio-tech companies.
- Forums
- ASX - By Stock
- CYP
- Ann: Efficacy for CYP MSC Technology in Preclinical Asthma Study-CYP.AX
Ann: Efficacy for CYP MSC Technology in Preclinical Asthma Study-CYP.AX, page-38
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
26.0¢ |
Change
0.005(1.96%) |
Mkt cap ! $46.70M |
Open | High | Low | Value | Volume |
25.5¢ | 26.0¢ | 25.5¢ | $2.003K | 7.837K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 62856 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.0¢ | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 52 | 0.265 |
2 | 64781 | 0.260 |
1 | 34500 | 0.255 |
1 | 27654 | 0.250 |
2 | 26342 | 0.245 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 3000 | 1 |
0.270 | 30000 | 1 |
0.290 | 4125 | 2 |
0.295 | 183892 | 1 |
0.300 | 85000 | 2 |
Last trade - 15.28pm 18/07/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |